-
1دورية أكاديمية
المؤلفون: Biagi M; College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA., Badowski M; Section of Infectious Diseases Pharmacotherapy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA badowski@uic.edu., Chiampas T; Section of Infectious Diseases Pharmacotherapy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA., Young J; Section of Infectious Diseases Pharmacotherapy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA., Vaughn P; Department of Medicine, Section of Infectious Diseases, College of Medicine, University of Illinois at Chicago, Chicago, IL, USA., Shicker L; Illinois Department of Corrections, Chicago, IL, USA., Patel M; Department of Medicine, Section of Infectious Diseases, College of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
المصدر: International journal of STD & AIDS [Int J STD AIDS] 2016 Aug; Vol. 27 (9), pp. 808-11. Date of Electronic Publication: 2015 Sep 16.
نوع المنشور: Case Reports; Journal Article
بيانات الدورية: Publisher: Sage Country of Publication: England NLM ID: 9007917 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1758-1052 (Electronic) Linking ISSN: 09564624 NLM ISO Abbreviation: Int J STD AIDS Subsets: MEDLINE
مواضيع طبية MeSH: Anti-HIV Agents/*adverse effects , Anti-HIV Agents/*therapeutic use , Glomerular Filtration Rate/*drug effects , HIV Infections/*drug therapy , Kidney/*drug effects , Tenofovir/*therapeutic use, Adenine/adverse effects ; HIV-1/drug effects ; Humans ; Male ; Middle Aged ; Nephrectomy ; Treatment Outcome
-
2دورية أكاديمية
المؤلفون: CHIAMPAS, Thomas D., BIAGI, Mark J., BADOWSKI, Melissa E.
المصدر: Pharmacy Practice (1886-3655); 2019, Vol. 17 Issue 3, p1-5, 5p, 2 Charts
-
3دورية أكاديمية
المؤلفون: Badowski, Melissa, Pérez, Sarah, Biagi, Mark, Littler, John
المصدر: Infectious Diseases & Therapy; Sep2016, Vol. 5 Issue 3, p329-352, 24p
مصطلحات موضوعية: ANTIRETROVIRAL agents, HIV infections, THERAPEUTICS, HIGHLY active antiretroviral therapy, LIFE expectancy, EPIDEMICS